KYNTRA BIO, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- KYNTRA BIO, INC. stock issued during period, value, stock options exercised for fiscal 2016 was $5.91M, a 41.58% decline from fiscal 2015.
- KYNTRA BIO, INC. stock issued during period, value, stock options exercised for fiscal 2015 was $10.11M, a 496.93% increase from fiscal 2014.
- KYNTRA BIO, INC. stock issued during period, value, stock options exercised for fiscal 2014 was $1.69M, a 1916.67% increase from fiscal 2013.
- KYNTRA BIO, INC. stock issued during period, value, stock options exercised for fiscal 2013 was $84.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2016-12-31 | $5.91M 10-K · filed 2017-03-01 | |
| 2015-12-31 | $10.11M 10-K · filed 2017-03-01 | |
| 2014-12-31 | $1.69M 10-K · filed 2017-03-01 | |
| 2013-12-31 | $84.00K 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |